Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002728 stock hub

SHE/002728 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002728is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002728

In the news

Latest news · SHE/002728

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E68.7

P25 23.5P50 41.3P75 83.2

ROE4.2

P25 -0.9P50 4.1P75 8.8

ROIC4.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002728 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

CNY

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,434
Employees Change	93%
Employees Change Percent	6.94
Enterprise value	CNY 5.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001WK6
Last refreshed	2026-05-10
Market cap	CNY 5.1B
Price	CNY 10.27
Price currency	CNY
Rev Per Employee	585,263.59x
Sector	Healthcare
Sic	2834
Symbol	she/002728
Website	https://www.tczy.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.48%
EV Earnings	66.62x
EV/EBIT	67.36x
EV/EBITDA	34.57x
EV/FCF	54.51x
EV/Sales	6.02x
FCF yield	1.81%
P/B ratio	2.78x
P/E ratio	68.73x
P/S ratio	6.11x
PE Ratio10 Y	42.36x
PE Ratio3 Y	64.78x
PE Ratio5 Y	49.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.94%
EBITDA Margin	17.42%
FCF margin	11.05%
Gross margin	52.47%
Gross Profit	CNY 440.3M
Gross Profit Growth	4.98%
Gross Profit Growth Q	-32.99%
Gross Profit Growth3 Y	-5.64%
Gross Profit Growth5 Y	6.91%
Net Income	CNY 75.9M
Net Income Growth	76.82%
Net Income Growth Q	-18.39%
Net Income Growth Years	1%
Net Income Growth3 Y	-31.69%
Net Income Growth5 Y	3.93%
Pretax Margin	9.29%
Profit Margin	9.04%
Profit Per Employee	CNY 52,906
Profitable Years	17
ROA	2.06
Roa5y	4.3
ROCE	3.98
ROE	4.16
Roe5y	8.94
ROIC	4.15
Roic5y	9.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.64%
Cagr1y	27.98%
Cagr3y	-2.48%
Cagr5y	13.81%
Div CAGR3	-46.78%
Div CAGR5	-33.44%
EPS Growth	84.39
EPS Growth Q	-16.67
EPS Growth Years	1
EPS Growth3 Y	-34.72
EPS Growth5 Y	-1.38
FCF Growth3 Y	-30.98%
FCF Growth5 Y	-4.39%
OCF Growth	56.65%
OCF Growth Q	-86.94%
OCF Growth10 Y	36.92%
OCF Growth3 Y	-23.52%
OCF Growth5 Y	-4.8%
Revenue Growth	2.56x
Revenue Growth Q	-28.89x
Revenue Growth Years	1x
Revenue Growth3 Y	-5.56x
Revenue Growth5 Y	5.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.37
Assets	CNY 2.3B
Cash	CNY 365.3M
Current Assets	CNY 891.9M
Current Liabilities	CNY 443.6M
Debt	CNY 288.6M
Debt EBITDA	CNY 1.97
Debt Equity	CNY 0.16
Debt FCF	CNY 3.11
Equity	CNY 1.8B
Interest Coverage	23.76
Liabilities	CNY 480.8M
Long Term Assets	CNY 1.4B
Long Term Liabilities	CNY 37.2M
Net Cash	CNY 76.8M
Net Cash By Market Cap	CNY 1.5
Net Cash Growth	280.7%
Net Debt EBITDA	CNY -0.52
Net Debt Equity	CNY -0.04
Net Debt FCF	CNY -0.83
Tangible Book Value	CNY 1.2B
Tangible Book Value Per Share	CNY 2.31
WACC	12.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.01
Inventory Turnover	1.5
Net Working Capital	CNY 371.5M
Quick ratio	1.35
Working Capital	CNY 448.2M
Working Capital Turnover	CNY 1.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.11%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.15
Dividend Years	11
Dividend Yield	1.46%
Ex Div Date	2025-07-25
Last Dividend	CNY 0.05
Payout Frequency	Annual
Payout Ratio	31.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	17.69%
1Y total return	27.96%
200-day SMA	10.77
3Y total return	-7.25%
50-day SMA	10.97
50-day SMA vs 200-day SMA	50over200
5Y total return	90.89%
All Time High	23.05
All Time High Change	-55.44%
All Time High Date	2015-05-28
All Time Low	4.65
All Time Low Change	121.1%
All Time Low Date	2014-07-31
ATR	0.28
Beta	1.56
Beta1y	0.72
Beta2y	0.72
Ch YTD	-5.35
High	10.29
High52	15.21
High52 Date	2025-11-14
High52ch	-32.48%
Low	9.98
Low52	8.01
Low52 Date	2025-05-08
Low52ch	28.38%
Ma50ch	-6.36%
Price vs 200-day SMA	-4.6%
RSI	42.35
RSI Monthly	50.66
RSI Weekly	44.47
Sharpe ratio	0.83x
Sortino ratio	1.49
Total Return	5.57%
Tr YTD	-5.35
Tr1m	-8.14%
Tr1w	2.7%
Tr3m	-21.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 75M
Operating Income Growth	22.7
Operating Income Growth Q	-14.23
Operating Income Growth3 Y	-36.03
Operating Income Growth5 Y	-7.49
Operating margin	8.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	297,951,817%
Net Borrowing	16,950,602
Shares Insiders	40.04%
Shares Institutions	2.17%
Shares Out	499,580,194
Shares Qo Q	-4.01%
Shares Yo Y	-4.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 92.7M
Average Volume	16,318,326.05x
Bv Per Share	3.59
CAPEX	CNY -73.7M
Ch10y	-10.81
Ch1m	-8.14
Ch1w	2.7
Ch1y	27.26
Ch3m	-21.9
Ch3y	-13.24
Ch5y	63.51
Ch6m	-8.47
Change	1.99%
Change From Open	1.99
Close	10.07
Days Gap	0
Depreciation Amortization	71,177,208
Dollar Volume	174,833,666
Earnings Date	2026-04-28
EBIT	CNY 75M
EBITDA	CNY 146.2M
EPS	CNY 0.15
F Score	6
FCF	CNY 92.7M
FCF EV Yield	1.83x
FCF Per Share	CNY 0.19
Financing CF	40,423,941
Fiscal Year End	December
Founded	2,002
Goodwill	517,600,671
Graham Number	3.47179
Graham Upside	-66.19
Income Tax	CNY 2.1M
Investing CF	-246,655,971
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2024-04-24
Last Split Type	Forward
Lynch Fair Value	CNY 0.75
Lynch Upside	-92.73
Ma150	11.3
Ma150ch	-9.12%
Ma20	10.53
Ma20ch	-2.48%
Net CF	-39,852,068
Next Earnings Date	2026-08-25
Open	10.07
P FCF Ratio	55.34
P OCF Ratio	30.84
Payment Date	2025-07-25
Position In Range	93.55
Ppne	721,944,551
Price Date	2026-05-08
Price EBITDA	CNY 35.09
Ptbv Ratio	4.3
Relative Volume	1.03x
Revenue	839,267,991x
Tax By Revenue	0.25x
Tax Rate	2.74%
Tr6m	-8.47%
Volume	17,023,726

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002728 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.15 annual per share

Payout ratio

+31.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-33.4%

0 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2025-07-25

Performance

SHE/002728 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002728?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.2%

Share of float held by funds and institutions

Insider ownership

+40.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.1%

Negative means the company is buying back shares.

Technical

SHE/002728 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-4.6%

50/200-day relationship not available

Beta (5Y)

1.56

More volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002728

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002728 stock rating?

she/002728 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002728 analysis?

The full report lives at /stocks/she/002728/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002728?

The latest report frames she/002728 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002728 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.